Global Export of Penicillins or Streptomycins in Dosage Forms Share by Country (US Dollars)

In 2023, India led the global export market for penicillins and streptomycins in dosage forms, holding the largest share with Austria and Italy following behind. Notable growth was observed in countries like Denmark and Indonesia, which saw significant year-on-year increases of 8.39% and 4.76% respectively. Conversely, countries like the United States and Ireland witnessed declines of -7.35% and -28.43%. Over the last five years, the compound annual growth rate (CAGR) has been indicative of a competitive market with varied performances between countries.

Future trends suggest an increased dependency on Asian producers like India and China due to cost-effectiveness, while European markets might consolidate through strategic partnerships to maintain competitive positioning. Moreover, fluctuations in global trade regulations and pharmaceutical demands are likely to impact the distribution dynamics significantly.